Platelet-Rich Plasma (PRP) Market Assessment & Forecast: 2018-2023 by Key Players Harvest Technologies, Exactech, Isto Biologics, Zimmer Biomet, Stryker Corporation, Arthrex, Regen Lab SA, DePuy Synthes, Nuo Therapeutics

Over the next five years, Qurate projects that Platelet Rich Plasma (PRP) will register a 13.3% CAGR in terms of revenue, reach US$ 400 million by 2023, from US$ 190 million in 2017

platelet-rich plasma report covers qualitative and quantitative analysis for major commercial segments segregated by types such as Pure Platelet-Rich Plasma (P-PRP), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), Pure Platelet-Rich Fibrin (P-PRF) and Leukocyte-Rich Platelet-Rich Fibrin (L-PRF). A section of the report delves into the origin area of the PRP market which is further categorized as autologous platelet-rich plasma, allogeneic platelet-rich plasma and homologous platelet-rich plasma. The PRP market is also analyzed on the basis of applications that includes orthopedic surgery, neurosurgery, cosmetic surgery, general surgery and other surgeries. Latter sections of the report focus on the trends and dynamics of the market in terms of competitor analysis. Increasing application areas of PRP and rising geriatric population which is more prone to diseases such as orthopedic diseases, neurological diseases and others drive the growth of the PRP market globally. Increasing incidences of sports injuries, technological advancements, rising number of cosmetic and orthopedic surgeries and growing preference for PRP usage are other factors supporting the growth of the global PRP market.

Get Easy Access to Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-55499

Harvest Technologies, Exactech, Inc., Isto Biologics, Zimmer Biomet, Stryker Corporation, Arthrex, Inc., Regen Lab SA, DePuy Synthes, and Nuo Therapeutics are some of the key players in the global platelet-rich plasma market. Top five players of the market accounted for more than 70%. However, presence of small/regional players pose a threat to the market share of key players.

The report segments the platelet-rich plasma market as follows:
Market by Type
Pure Platelet-Rich Plasma (P-PRP)
Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
Pure Platelet-Rich Fibrin (P-PRF)
Leukocyte-Rich Platelet-Rich Fibrin (L-PRF)

Market by Origin
Autologous Platelet-Rich Plasma
Allogeneic Platelet-Rich Plasma
Homologous Platelet-Rich Plasma

Market by Applications
Orthopedic Surgery
Neurosurgery
Cosmetic Surgery
General Surgery
Other Surgeries

Market by Geography
North America
Europe
Asia Pacific
Latin America
Middle-East
Africa

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-55499

For each of these segments and sub-segments, market estimates have been provided from 2015 to 2021 (historic data for 2015 and 2016, and forecast from 2017 to 2021)

Extended geography analysis for PRP types:
The report not only provides geographical analysis of the overall PRP market, it also segments each geographical region further by PRP types.

The PRP market report provides market share for key players in the market:
The report provides market share analysis for major players in the market and mentions more than 10 players in the global PRP market.

The report also explains other factors impacting the market:
Various factors driving and impeding the growth of the PRP market are explained in the report. The report also includes mentions of recent developments in the market such as new product launches, mergers and acquisitions.

Purchase Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-55499/

Increasing number of sports injuries, quick recovery, cost effectiveness, and growing application areas (trauma surgery, general surgery, dermatology, long bone healing and others) are some of the prominent factors that drive the growth of autologous PRP segment market from 2018 to 2023. Majority of the research currently under progress has been focused on autologous PRP treatment. It is expected that in the near future autologous PRP would find more applications in treatment of chronic disorders. Growing demand for cosmetic procedures is also a key driver for the autologous PRP market. North America dominated the global PRP market with a share more than 40%. The dominance of the region was majorly due to trend for rapid adoption of new technology, and is supported by increasing number of orthopedic and cosmetic surgeries in the region. Asia Pacific region is emerging as a hub for expensive medical treatments. Large numbers of patients are traveling to South East Asian countries for treatment for various disorders, mainly including cosmetic procedures. This has potentially driven demand for PRP treatment in this region.

Get Discount on this Report@ https://www.qurateresearch.com/report/discount/HnM/QBI-LPI-HnM-55499

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
IN +919881074592
info@qurateresearch.com
https://www.qurateresearch.com/

This release was published on openPR.